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Abstract 
Cutaneous botryomycosis is a chronic focal infection characterized by a granulomatous 
inflammatory response to bacterial pathogens such as Staphylococcus aureus. Treatment 
requires antibiotic therapy and may also require surgical debridement. We employed topical 
heat therapy and oral minocycline. The lesions became flattened and pigmented after 1 
month. We consider that this simple treatment can be an effective and harmless 
complementary therapy for cutaneous botryomycosis.  
 
Introduction 
Skin staphylococcal infections usually show acute inflammatory skin changes such as 
impetigo and furuncles. However, certain individuals, possibly those with an 
immunodeficiency, may show a unique, chronic focal granulomatous lesion that is 
noted clinically as botryomycosis. To treat such a case, we employed topical heat 
therapy together with oral antibiotics to cure botryomycosis without using any surgical 
measures. 
Case Report 
A 53-year-old Japanese woman with a 6-year history of bronchial asthmatic attacks for which she 
occasionally used budesonide inhalation presented with a 3-month history of asymptomatic, 
scattered, red papules on the dorsum of the right foot (fig. 1). She denied any preceding trauma or Case Rep Dermatol 2012;4:114–118 
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surgical procedures at this site. The lesions gradually increased in size despite the tentative 
application of a topical corticosteroid. Thus, suspecting infectious granulomatous lesions, in addition 
to bacterial and fungal cultures we surgically removed one of the red papules for histopathological 
studies. Histopathologically, the papule showed the presence of basophilic bacterial granules 
surrounded by eosinophilic amorphous materials, constituting a typical Splendore-Hoeppli 
phenomenon in the mid-dermis [1] (fig. 2). The bacteriological culture of a part of the biopsy 
specimen yielded a colony of Staphylococcus aureus, whereas no other growth for fungi or 
actinomycetes could be observed. The results of the laboratory investigations excluded any risk 
factors such as diabetes mellitus, collagen disease or HIV infection. There was also no history of 
alcoholism. Despite the prolonged budesonide inhalation for bronchial asthma in the past, her 
neutrophil phagocytotic function and immunological parameters such as IgG levels and CD4 count 
were found to be all within normal limits. Based on these results, we made a diagnosis of cutaneous 
botryomycosis caused by S. aureus. Since the patient was allergic to a variety of drugs containing  
β-lactam antibiotics, we started oral administration of minocycline at a dose of 200 mg/day together 
with topical heat therapy, using a commercially available, disposable pocket warmer. She applied the 
pack daily as long as possible, taking care not to cause a burn injury. With this treatment, we noticed 
substantial clinical improvement of the lesions after 1 month, and the treatment was continued for 
another 4 months until all lesions became flattened and pigmented (fig. 3). There was no subsequent 
relapse in the following 8 months. 
Discussion 
Botryomycosis is a unique, chronic bacterial granulomatous disease that often 
involves the skin, subcutaneous tissues and, rarely, the viscera [2]. Its treatment 
requires antibiotic therapy and, in most cases, surgical debridement. The selection of 
antibiotics should be tailored to the results of bacterial cultures [3]. Even though such 
patients may not show any signs of immunodeficiency, it sometimes happens that 
antibiotic therapy alone may be insufficient [4, 5]. 
The present patient did not show any laboratory-proven abnormalities in her 
immune system such as T cell defects, neutrophil function or a previous 
immunosuppressive condition associated with the history of other opportunistic 
infections. However, it was reported that T cell defects and impaired neutrophil, 
monocyte and/or macrophage function play a significant role in the development of 
botryomycosis [6]; therefore, we cannot exclude the possibility that her past 6-year 
history of occasional corticosteroid inhalation for the control of bronchial asthma might 
have influenced her immune system. In fact, botryomycosis occurs most commonly 
among immunocompromised patients [7]. Thus, besides antibiotic therapy, we also 
started topical heat therapy based on the findings that it was a safe and effective 
method for treating sporotrichosis and chromoblastomycosis when antifungal agents 
were not available in Japan [8]. The temperature of the commonly used heating packs, 
which are available as body warmers in Japan, rises up to 63°C and lasts 12 h, with an 
average temperature of 53°C in wintertime. Being a source of heat, any device that 
emits constant heat to keep the skin surface temperature at 40–43°C should be 
wrapped with a piece of cloth because the skin cannot tolerate persistent heat higher 
than that [8, 9]. Therefore, a temperature-dependent germicidal effect for S. aureus 
cannot be expected since the highest temperature limit for its growth is 48°C after 7 
days of incubation [10]. 
Although the precise mechanisms underlying the effectiveness of topical heat 
therapy are not completely clear, we think that heat exerts at least a cytostatic effect on 
the organisms, which facilitates the phagocytic function of the host defense Case Rep Dermatol 2012;4:114–118 
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mechanisms in addition to its possible effect on host immunity. The skin surface 
temperature of the ankle is about 30°C [11]. An increase of the skin surface 
temperature from 30 to 43°C can lead to an increased blood flow, which would result in 
the increased activation of antibacterial defense. We consider that this simple 
treatment can be an effective and harmless complementary therapy for cutaneous 
botryomycosis. To our knowledge, this is the first report of botryomycosis successfully 
treated by minocycline combined with topical heat therapy. 
 
 
 
 
 
 
Fig. 1. Dark red papuloerythematous lesions on the dorsal and lateral side of the right foot. 
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Fig. 2. a Basophilic granules surrounded by mixed cell granuloma in the lower dermis (original 
magnification ×50). b Magnified feature of bacterial clumps. Grain surrounded by an eosinophilic 
material (the Splendore-Hoeppli phenomenon; original magnification ×200). 
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Fig. 3. Four months after the initial therapy. 
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